Lotusmedica - Company finances
|
EUR
|
2019
From: 2019-01-22
To: 2019-12-31
|
2020
From: 2020-01-01
To: 2020-12-31
|
2021
From: 2021-01-01
To: 2021-12-31
|
2022
From: 2022-01-01
To: 2022-12-31
|
2023
From: 2023-01-01
To: 2023-12-31
|
2024
From: 2024-01-01
To: 2024-12-31
|
2025
From: 2025-01-01
To: 2025-12-31
|
|---|---|---|---|---|---|---|---|
|
Financial data
|
|||||||
| Sales revenue | 14,632 | 89,836 | 209,876 | 323,219 | 476,516 | 687,056 | 784,774 |
| Profit before tax | - | - | - | - | - | - | - |
| Net profit | -1,283 | 20,484 | 12,357 | 8,875 | 27,109 | 13,049 | 23,783 |
| Equity | 1,217 | 21,701 | 26,859 | 20,475 | 31,584 | 43,249 | 59,376 |
| Liabilities | 1,220 | 13,111 | 40,581 | 73,787 | 78,509 | 65,281 | 96,474 |
| Non-current assets | 477 | 3,878 | 34,455 | 49,774 | 40,121 | 31,014 | 67,223 |
| Current assets | 1,912 | 22,323 | 32,336 | 43,126 | 68,719 | 75,115 | 87,186 |
| Total assets | 2,389 | 26,201 | 66,791 | 92,900 | 108,840 | 106,129 | 154,409 |
|
Taxes paid
|
|||||||
| STI taxes | - | - | - | - | 72,570 | 115,117 | 125,061 |
| Social insurance contributions | - | - | - | - | 77,528 | 124,567 | 137,001 |
|
Financial indicators
|
|||||||
| Revenue change y/y | - | +514.0% | +133.6% | +54.0% | +47.4% | +44.2% | +14.2% |
| ROA Return on Assets (ROA). The ratio of net profit to assets. Indicates the company's efficiency. | -53.7% | 78.2% | 18.5% | 9.6% | 24.9% | 12.3% | 15.4% |
| ROE Return on equity. The ratio of net profit to equity. Shows the return to shareholders. | -105.4% | 94.4% | 46.0% | 43.3% | 85.8% | 30.2% | 40.1% |
| Profit margin Net profit margin. Shows the overall profitability of the company. | -8.8% | 22.8% | 5.9% | 2.7% | 5.7% | 1.9% | 3.0% |
| EBT% EBT (Earnings Before Taxes) to revenue ratio. Shows the overall profitability of the company. | - | - | - | - | - | - | - |
| Liabilities/Equity The debt-to-equity ratio shows the company's capital structure. | 1.0 | 0.6 | 1.5 | 3.6 | 2.5 | 1.5 | 1.6 |
| Revenue per employee Ratio of revenue to the average annual number of employees. Indicates company efficiency. | 2,124 | 7,046 | 10,034 | 12,313 | 18,505 | 22,588 | 26,830 |
Sales revenue
See Scoris data in Google Search
Mark Scoris as a favorite source. One click, no registration.
Lotusmedica - Social security debts
| From | To | Debt, € |
|---|---|---|
| 2026-05-17 | 2026-06-04 | 0.01 |
| 2022-07-25 | 2022-08-07 | 1.29 |
| 2022-04-19 | 2022-04-21 | 613.15 |
Lotusmedica - VMI tax arrears
| From | To | Overdue, € |
|---|---|---|
| 2026-06-28 | 2026-06-30 | 129.72 |
| 2025-03-05 | 2025-03-06 | 47.3 |
VMI debt information has been collected since 2024-10-07. Debts for older periods will not be displayed.
Analysis of the company's financial position
This description was generated by artificial intelligence.
Report if inaccurate.
Lotusmedica, UAB, code 304994501, is a Private Limited Liability Company engaged in other human health activities n.e.c. In the latest financial year, 2025, the company generated revenue of €784.8K and net profit of €23.8K, corresponding to a profit margin of 3.0%. Revenue increased by 14.2% year on year and by 64.7% over two years, showing steady top-line expansion. Profitability was more volatile: net profit fell from €27.1K in 2023 to €13.0K in 2024, then recovered in 2025. Total assets rose to €154.4K, while equity increased to €59.4K and liabilities to €96.5K. The equity ratio stood at 38.5% and debt-to-equity at 1.62, indicating a moderate leverage position. Asset turnover was 5.08x, supported by revenue per employee of €27.1K and profit per employee of €820. Return on equity reached 40.0% and return on assets 15.4%, reflecting efficient use of the company’s capital base in 2025.